Zhejiang Medicine Co., Ltd.   Report issue

For profit Phase 1
Founded: Taizhou China (1972)
Status: No NME R&D (1972)

Organization Overview

First Clinical Trial
2015
NCT02604498
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

arx788 (1 trial)

nemonoxacin (2 trials)

Drugs in Other Trials (1)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Liver Diseases (Phase 1)

Neoplasms (Phase 1)

Renal Insufficiency (Phase 1)

Stomach Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3